VITASPRING BIOMEDICAL CO., LTD. Increase (Decrease) in Accounts Receivable
VITASPRING BIOMEDICAL CO., LTD. (VSBC) reported Increase (Decrease) in Accounts Receivable of $0 for the 12-month period ending 2025-01-31, per its 10-K filed 2026-06-08.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-06-08
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in accounts receivable for the quarter ending 2025-01-31 was $0.00.
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in accounts receivable for the quarter ending 2024-10-31 was $0.00.
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in accounts receivable for the quarter ending 2024-07-31 was $0.00.
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in accounts receivable for the quarter ending 2024-04-30 was $0.00.
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in accounts receivable for fiscal 2025 was $0.00.
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in accounts receivable for fiscal 2024 was -$380.00K.
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in accounts receivable for fiscal 2023 was -$2.54M, a 185.99% decline from fiscal 2022.
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in accounts receivable for fiscal 2022 was $2.95M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2025-01-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-08 | $0.00 derived: sum of 2 quarters · filed 2026-06-08 | $0.00 derived: sum of 3 quarters · filed 2026-06-08 | $0.00 10-K · filed 2026-06-08 |
| 2024-10-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-05-06 | $0.00 10-Q · filed 2026-05-06 | -$60.00K derived: sum of 4 quarters · filed 2026-06-08 |
| 2024-07-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-04-22 | $0.00 10-Q · filed 2026-04-22 | -$60.00K derived: sum of 3 quarters · filed 2026-06-08 | -$130.00K derived: sum of 4 quarters · filed 2026-06-08 |
| 2024-04-30 | $0.00 10-Q · filed 2026-04-02 | -$60.00K derived: sum of 2 quarters · filed 2026-06-08 | -$130.00K derived: sum of 3 quarters · filed 2026-06-08 | -$230.00K derived: sum of 4 quarters · filed 2026-06-08 |
| 2024-01-31 | -$60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-08 | -$130.00K derived: sum of 2 quarters · filed 2026-06-08 | -$230.00K derived: sum of 3 quarters · filed 2026-06-08 | -$380.00K 10-K · filed 2026-06-08 |
| 2023-10-31 | -$70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06 | -$170.00K derived: sum of 2 quarters · filed 2026-05-06 | -$320.00K 10-Q · filed 2026-05-06 | -$1.93M derived: sum of 4 quarters · filed 2026-05-06 |
| 2023-07-31 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-04-22 | -$250.00K 10-Q · filed 2026-04-22 | -$1.86M derived: sum of 3 quarters · filed 2026-04-22 | |
| 2023-04-30 | -$150.00K 10-Q · filed 2026-04-02 | -$1.76M derived: sum of 2 quarters · filed 2026-04-02 | ||
| 2023-01-31 | -$1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$2.54M 10-K · filed 2026-03-12 | ||
| 2022-10-31 | -$931.89K 10-Q · filed 2026-01-30 | |||
| 2022-04-30 | -$831.89K 10-Q · filed 2026-01-13 | |||
| 2022-01-31 | $2.95M 10-K · filed 2025-12-01 |